BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 27510505)

  • 1. The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence.
    Ferrari F; Villa RF
    Mol Neurobiol; 2017 Sep; 54(7):4847-4865. PubMed ID: 27510505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurobiology of depression and antidepressant action.
    Willner P; Scheel-Krüger J; Belzung C
    Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 1):2331-71. PubMed ID: 23261405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
    Nikisch G
    Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.
    Gupta D; Radhakrishnan M; Kurhe Y; Thangaraj D; Prabhakar V; Kanade P
    Acta Pharmacol Sin; 2014 Dec; 35(12):1493-503. PubMed ID: 25418380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression.
    Massart R; Mongeau R; Lanfumey L
    Philos Trans R Soc Lond B Biol Sci; 2012 Sep; 367(1601):2485-94. PubMed ID: 22826347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
    Ressler KJ; Nemeroff CB
    Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression.
    Peng GJ; Tian JS; Gao XX; Zhou YZ; Qin XM
    Curr Neuropharmacol; 2015; 13(4):514-23. PubMed ID: 26412071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel insights into the pharmacological effects of resveratrol on the management of depression: a short review.
    Xu YY; Liang J; Xia QR
    Pharmazie; 2017 Sep; 72(9):499-502. PubMed ID: 29441975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-like Effect of Bacopaside I in Mice Exposed to Chronic Unpredictable Mild Stress by Modulating the Hypothalamic-Pituitary-Adrenal Axis Function and Activating BDNF Signaling Pathway.
    Zu X; Zhang M; Li W; Xie H; Lin Z; Yang N; Liu X; Zhang W
    Neurochem Res; 2017 Nov; 42(11):3233-3244. PubMed ID: 28758176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New trends in the neurobiology and pharmacology of affective disorders.
    Lasoń W; Budziszewska B; Basta-Kaim A; Kubera M; Maes M
    Pharmacol Rep; 2013; 65(6):1441-50. PubMed ID: 24552991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological modulation of HPA axis in depression - new avenues for potential therapeutic benefits.
    Maric NP; Adzic M
    Psychiatr Danub; 2013 Sep; 25(3):299-305. PubMed ID: 24048401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
    Budziszewska B
    Pol J Pharmacol; 2002; 54(4):343-9. PubMed ID: 12523487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel agents in development for the treatment of depression.
    Grady MM; Stahl SM
    CNS Spectr; 2013 Dec; 18 Suppl 1():37-40; quiz 41. PubMed ID: 24252548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis.
    Cai L; Li R; Tang WJ; Meng G; Hu XY; Wu TN
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1332-41. PubMed ID: 25914157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of endocrine hormones for treating depression.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Dec; 48(12):13-6. PubMed ID: 21117521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic activation of NPFFR2 stimulates the stress-related depressive behaviors through HPA axis modulation.
    Lin YT; Liu TY; Yang CY; Yu YL; Chen TC; Day YJ; Chang CC; Huang GJ; Chen JC
    Psychoneuroendocrinology; 2016 Sep; 71():73-85. PubMed ID: 27243477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression.
    Kunugi H; Hori H; Adachi N; Numakawa T
    Psychiatry Clin Neurosci; 2010 Oct; 64(5):447-59. PubMed ID: 20923424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tianeptine, an atypical pharmacological approach to depression.
    Alamo C; García-Garcia P; Lopez-Muñoz F; Zaragozá C
    Rev Psiquiatr Salud Ment (Engl Ed); 2019; 12(3):170-186. PubMed ID: 30612921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways.
    Taylor C; Fricker AD; Devi LA; Gomes I
    Cell Signal; 2005 May; 17(5):549-57. PubMed ID: 15683730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of the hypothalamo-hypophyseal-adrenocortical system in the specific activity of antidepressive agents].
    Arushanian EB; El'bek'ian KS
    Eksp Klin Farmakol; 1995; 58(3):65-70. PubMed ID: 7663305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.